Clinical Trials Directory

Trials / Unknown

UnknownNCT05458388

Different Endoscopic Gastric Cancer Risk Assessments

Different Endoscopic Gastric Cancer Risk Assessments for the Detection of Early Gastric Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
3,500 (estimated)
Sponsor
Yanqing Li · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The Kimura-Takamoto classification established in Japan can observe the extent of gastric atrophy in real-time under endoscopy, and diffuse atrophy also indicates an increased risk of gastric cancer. Recent studies have found that the evaluation of intestinal metaplasia score (EGGIM score) of various stomach parts by electronic staining can well identify OLGIM III\\ IV patients. Although the Kimura-Takamoto classification and EGGIM score can evaluate the risk of gastric cancer in patients, only in cross-sectional studies, it is not clear the diagnostic value of risk assessment in population screening. Early gastric cancer has the characteristics of hidden lesions and a high rate of clinical missed diagnosis. Concentrating high-risk groups through risk scores is expected to guide endoscopic doctors to conduct a targeted careful examination. However, it is not clear whether Kimura-Takamoto classification and EGGIM score can improve the detection rate of early gastric cancer in clinical practice.

Conditions

Interventions

TypeNameDescription
PROCEDUREKimura-Takemoto classificationAll patients were given two risk scores, the order of which was randomly determined.
PROCEDUREEGGIMAll patients were given two risk scores, the order of which was randomly determined.

Timeline

Start date
2022-07-12
Primary completion
2024-12-31
Completion
2025-07-04
First posted
2022-07-14
Last updated
2022-07-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05458388. Inclusion in this directory is not an endorsement.